Cargando…
Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cys...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808506/ https://www.ncbi.nlm.nih.gov/pubmed/33466160 http://dx.doi.org/10.1097/MD.0000000000024054 |
_version_ | 1783636913053237248 |
---|---|
author | Shi, Dan Dong, Guo-Qiu Shen, Ke-Ren Pan, Yao Wei, Shu-Mei Chen, Ying Yu, Ri-Sheng |
author_facet | Shi, Dan Dong, Guo-Qiu Shen, Ke-Ren Pan, Yao Wei, Shu-Mei Chen, Ying Yu, Ri-Sheng |
author_sort | Shi, Dan |
collection | PubMed |
description | RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cystic and solid mass during a physical checkup. DIAGNOSES: The mass was mainly multiseptated in the cystic portion and had a bead-like, lobulated appearance. The solid portion showed restricted diffusion on diffusion-weighted imaging and obvious homogeneous enhancement. The cystic portion showed ring-like and septal enhancement. The patient was diagnosed with a grade 2 (G2) NET of the retroperitoneum after surgery. INTERVENTIONS: The patient underwent resection of the large retroperitoneal tumor. OUTCOMES: The patient returned 20 months later with tumor recurrence in the retroperitoneum. She was enrolled in a clinical trial for sulfatinib, and the mass was considerably reduced in size after 4 months. During a nearly 1.5-year follow-up, the mass gradually became slightly enlarged. The expression of somatostatin receptor 2 (SSTR2) was detected, and somatuline was administered as the current treatment. LESSONS SUBSECTIONS: When a retroperitoneal mass presents as a well-defined cystic or solid hypervascular mass with a fibrous capsule, a primary retroperitoneal NET should be considered in the differential diagnosis. |
format | Online Article Text |
id | pubmed-7808506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78085062021-01-15 Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report Shi, Dan Dong, Guo-Qiu Shen, Ke-Ren Pan, Yao Wei, Shu-Mei Chen, Ying Yu, Ri-Sheng Medicine (Baltimore) 6800 RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cystic and solid mass during a physical checkup. DIAGNOSES: The mass was mainly multiseptated in the cystic portion and had a bead-like, lobulated appearance. The solid portion showed restricted diffusion on diffusion-weighted imaging and obvious homogeneous enhancement. The cystic portion showed ring-like and septal enhancement. The patient was diagnosed with a grade 2 (G2) NET of the retroperitoneum after surgery. INTERVENTIONS: The patient underwent resection of the large retroperitoneal tumor. OUTCOMES: The patient returned 20 months later with tumor recurrence in the retroperitoneum. She was enrolled in a clinical trial for sulfatinib, and the mass was considerably reduced in size after 4 months. During a nearly 1.5-year follow-up, the mass gradually became slightly enlarged. The expression of somatostatin receptor 2 (SSTR2) was detected, and somatuline was administered as the current treatment. LESSONS SUBSECTIONS: When a retroperitoneal mass presents as a well-defined cystic or solid hypervascular mass with a fibrous capsule, a primary retroperitoneal NET should be considered in the differential diagnosis. Lippincott Williams & Wilkins 2021-01-15 /pmc/articles/PMC7808506/ /pubmed/33466160 http://dx.doi.org/10.1097/MD.0000000000024054 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 6800 Shi, Dan Dong, Guo-Qiu Shen, Ke-Ren Pan, Yao Wei, Shu-Mei Chen, Ying Yu, Ri-Sheng Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title | Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title_full | Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title_fullStr | Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title_full_unstemmed | Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title_short | Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report |
title_sort | primary cystic and solid neuroendocrine tumor of the retroperitoneum: a case report |
topic | 6800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808506/ https://www.ncbi.nlm.nih.gov/pubmed/33466160 http://dx.doi.org/10.1097/MD.0000000000024054 |
work_keys_str_mv | AT shidan primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT dongguoqiu primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT shenkeren primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT panyao primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT weishumei primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT chenying primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport AT yurisheng primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport |